Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients

Journal of Surgical Oncology

Volumn 73, Issue 3, 2000, Pages 153-157

  Harrison, Lawrence E ^a   Choe, Jiw K ^a   Goldstein, Marsha ^a   Meridian, Ara ^a   Kim, Steve H ^a   Clarke, Kevin ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Gastric cancer; Immunohistochemical; Prognostic markers

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0034063660     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(200003)73:3<153::AID-JSO8>3.0.CO;2-4     Document Type: Article

References (12)

1. Roder JD, Bottcher K, Siewert JR, et al.: The German Gastric Cancer TNM Study Group: Prognostic factors in gastric carcinoma: Results of the German Gastric Carcinoma Study. Cancer 1993;72:2089-2097.
2. Harrison L, Karpeh M, Brennan M: Proximal gastric cancers resected via a transabdominal-only approach. Ann Surg 1997;225: 678-685.
3. Jeffers MD, O'Dowd GM, Mulchahy H, et al.: The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994;172:183-187.
4. Nasser IA, Lee A, Bosari S, et al.: Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 1993;24:957.
5. Ishida K, Katsuyama T, Sugiyama A, et al.: Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997;79:1069-1076.
6. Izbicki JR, Hosch SB, Pichlmeier U, et al.: Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997;337:1188-1194.
7. 1 lymph node metastases. Br J Surg 1996;83:1144-1147.
8. Maehara Y, Oshiro T, Endo K, et al.: Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996;119:397-402.
9. Harrison L, Karpeh M, Brennan MF: Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg 1998;2:126-131.
10. Roder JD, Bonenkamp JJ, Craven J, et al.: Lymphadenectomy for gastric cancer in clinical trials: Update. World J Surg 1995;19: 546-553.
11. Bonekamp JJ, van de Velde CJH, Hermans J: Randomized trial of extended lymph node dissection for gastric cancer. In Siewert JR, Roder JD (eds): "2nd International Gastric Cancer Congress." Bologna: Monduzi Editore, 1997:1111-1116.
12. Natsugoe S, Mueller J, Stein HJ, et al.: Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: Frequency, associated tumor characteristics and impact on prognosis. Cancer 1998;83:858-866.